Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 918-139-9 | CAS number: 1228577-90-9
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: study in full compliance with OECD Guideline
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 008
- Report date:
- 2008
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Skin sensitization study using guinea pig maximisation test following OECD guideline 406 was conducted.
Test material
- Reference substance name:
- 1,2-Diaminotoluene, propoxylated
- EC Number:
- 918-139-9
- Cas Number:
- 1228577-90-9
- Molecular formula:
- (C3H6O)n (C3H6O)n (C3H6O)n (C3H6O)n C7H10N2 sum of n: >1 - <8.5
- IUPAC Name:
- 1,2-Diaminotoluene, propoxylated
- Details on test material:
- - Name of test material (as cited in study report): NLP#10, Tercarol 5903
- Physical state: liquid, strong viscous
- Analytical purity: content 100%
- Impurities (identity and concentrations):
- Molecular weight: Mn = 340 g/mole
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- other: Crl: HA
- Sex:
- female
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal
- Vehicle:
- other: polyethylene glycol 400; formulations were heated up in a water bath (40°C) for approximately 30 minutes
- Concentration / amount:
- 5% for intradermal induction
50% for topical induction
50% for first challenge
25% for second challenge
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: polyethylene glycol 400; formulations were heated up in a water bath (40°C) for approximately 30 minutes
- Concentration / amount:
- 5% for intradermal induction
50% for topical induction
50% for first challenge
25% for second challenge
- No. of animals per dose:
- 10
- Details on study design:
- RANGE FINDING TESTS:
- for intradermal induction: concentrations of 0, 1, 2.5, and 5 % were tested
- for topical induction: concentrations of 0, 12, 25, and 50 % were tested
- for challenge: concentrations of 0, 12, 25, and 50 % were tested
Application of 100% was not possible because of the high vicosity of the test material.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2; first induction intradermal, second induction topical 7 days later
- Exposure period: 48 h occusive in the topical induction
- Test groups: 10 animals
- Control group: 5 animals
- Concentrations: 5 % for intradermal induction, 50 % for topical induction
B. CHALLENGE EXPOSURE
- No. of exposures: 2, first challenge topical and second challenge topical
- Day(s) of challenge: first challenge started 3 weeks after intradermal induction, second challenge 7 days later
- Exposure period: 24 hours semiocclusive for each challenge
- Concentrations: 50 % for first challenge, 25 % for second challenge
- Evaluation (hr after challenge): 48 and 72 hours after start of challenge
Reliability of the test system is routinely confirmed by alpha hexyl cinnamic aldehyde. - Challenge controls:
- yes: control group animals were treated in challenge experiments according to test group animals
- Positive control substance(s):
- not required
Results and discussion
- Positive control results:
- Routinely performed tests with positive controls confirmed the reliability of the test system.
In vivo (non-LLNA)
Resultsopen allclose all
- Group:
- positive control
- Remarks on result:
- not measured/tested
- Remarks:
- Positive control was not tested.
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 50%
- No. with + reactions:
- 3
- Total no. in group:
- 5
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 50%. No with. + reactions: 3.0. Total no. in groups: 5.0. Clinical observations: none.
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- negative control
- Dose level:
- 50%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 72.0. Group: negative control. Dose level: 50%. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: none.
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 5
- Total no. in group:
- 10
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 50%. No with. + reactions: 5.0. Total no. in groups: 10.0. Clinical observations: none.
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 72.0. Group: test group. Dose level: 50%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none.
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 25%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- none
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 48.0. Group: negative control. Dose level: 25%. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: none.
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 25%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 48.0. Group: test group. Dose level: 25%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none.
- Reading:
- rechallenge
- Hours after challenge:
- 72
- Group:
- negative control
- Dose level:
- 25%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- none
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 72.0. Group: negative control. Dose level: 25%. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: none.
- Reading:
- rechallenge
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 25%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 72.0. Group: test group. Dose level: 25%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none.
Any other information on results incl. tables
The first challenge with the 50% test item formulation led to skin effects (grade 1) in 5 of 10 animals of the test item group (50%) and in 3 of 5 animals (grade 1) of the control group (60%). The second challenge with the 25% test item formulation led to no skin effects in the animals of the test item group and the control group. In summary, under the conditions of the maximization test and with respect to the evaluation criteria the test item therefore exhibits no skin-sensitization potential.
Applicant's summary and conclusion
- Conclusions:
- not sensitising
- Executive summary:
NLP#10 (ortho-toluene diamine, propoxylated) was tested in the Guinea Pig Maximization Test (GPMT) on 15 female test animals (10 for the test item group, 5 control animals) for its skin sensitizing properties (OECD 406). Concentrations of 5% (intradermal induction), 50% (topical induction and first challenge) and 25% (second challenge) of the test material in PEG 400 were used. Under the conditions of the test NLP#10 was shown to exhibit no skin sensitization potential.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
